Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Gynecologic Oncology
>
2013
>
24
>
1
Volume:
24
Issue:
1
1. Book Review: The creative destruction of medicine: how the digital revolution will create better healthcare.
Page:98—99
2. Pharmacokinetics and cytotoxic effect of selenium compounds in rodent cancer xenograft model for therapy experiment.
Page:96—97
3. Minimal deviation adenocarcinoma of the cervix and tumorlets of sex-cord stromal tumor with annular tubules of the ovary in Peutz-Jeghers syndrome.
Page:92—95
4. Advanced ovarian cancer: what should be the standard of care?.
Page:83—91
5. Major clinical research advances in gynecologic cancer in 2012.
Page:66—82
6. Establishment of a Korea HPV cohort study.
Page:59—65
7. Effect of ovarian tumor characteristics on venous thromboembolic risk.
Page:52—58
8. Histologic distribution of borderline ovarian tumors worldwide: a systematic review.
Page:44—51
9. Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review.
Page:37—43
10. Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer.
Page:29—36
11. Integration of robotics into two established programs of minimally invasive surgery for endometrial cancer appears to decrease surgical complications.
Page:21—28
12. Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group.
Page:14—20
13. Knowledge about HPV, relation between HPV and cervix cancer and acceptance of HPV vaccine in women in eastern region of Turkey.
Page:7—13
14. ASGO 2nd International Workshop on Gynecologic Oncology.
Page:3—6
15. Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?.
Page:1—2